nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—PIP4K2C—rheumatoid arthritis	0.462	0.945	CbGaD
Erlotinib—ALB—Auranofin—rheumatoid arthritis	0.0293	0.101	CbGbCtD
Erlotinib—ABCG2—Leflunomide—rheumatoid arthritis	0.0274	0.0942	CbGbCtD
Erlotinib—ALB—rheumatoid arthritis	0.027	0.0552	CbGaD
Erlotinib—CYP1B1—Dexamethasone—rheumatoid arthritis	0.0178	0.0611	CbGbCtD
Erlotinib—ABCG2—Sulfasalazine—rheumatoid arthritis	0.0169	0.0582	CbGbCtD
Erlotinib—ABCG2—Hydrocortisone—rheumatoid arthritis	0.0136	0.0467	CbGbCtD
Erlotinib—ABCG2—Cyclosporine—rheumatoid arthritis	0.0128	0.0441	CbGbCtD
Erlotinib—CYP1A2—Leflunomide—rheumatoid arthritis	0.0113	0.0389	CbGbCtD
Erlotinib—CYP3A5—Sulfasalazine—rheumatoid arthritis	0.00937	0.0323	CbGbCtD
Erlotinib—ALB—Prednisone—rheumatoid arthritis	0.00932	0.0321	CbGbCtD
Erlotinib—ABCG2—Dexamethasone—rheumatoid arthritis	0.00844	0.0291	CbGbCtD
Erlotinib—ABCB1—Methylprednisolone—rheumatoid arthritis	0.00805	0.0277	CbGbCtD
Erlotinib—CYP1A1—Dexamethasone—rheumatoid arthritis	0.00779	0.0268	CbGbCtD
Erlotinib—CYP3A5—Hydrocortisone—rheumatoid arthritis	0.00752	0.0259	CbGbCtD
Erlotinib—CYP2C8—Hydrocortisone—rheumatoid arthritis	0.00723	0.0249	CbGbCtD
Erlotinib—CYP3A5—Cyclosporine—rheumatoid arthritis	0.0071	0.0244	CbGbCtD
Erlotinib—CYP2C8—Cyclosporine—rheumatoid arthritis	0.00683	0.0235	CbGbCtD
Erlotinib—ABCG2—Methotrexate—rheumatoid arthritis	0.00679	0.0234	CbGbCtD
Erlotinib—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.00654	0.0225	CbGbCtD
Erlotinib—ABCB1—Betamethasone—rheumatoid arthritis	0.00523	0.018	CbGbCtD
Erlotinib—ABCB1—Prednisolone—rheumatoid arthritis	0.00516	0.0178	CbGbCtD
Erlotinib—ABCB1—Hydrocortisone—rheumatoid arthritis	0.0049	0.0168	CbGbCtD
Erlotinib—ABCB1—Prednisone—rheumatoid arthritis	0.00488	0.0168	CbGbCtD
Erlotinib—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.00482	0.0166	CbGbCtD
Erlotinib—CYP3A5—Dexamethasone—rheumatoid arthritis	0.00468	0.0161	CbGbCtD
Erlotinib—ALB—Methotrexate—rheumatoid arthritis	0.00468	0.0161	CbGbCtD
Erlotinib—ABCB1—Cyclosporine—rheumatoid arthritis	0.00462	0.0159	CbGbCtD
Erlotinib—CYP2C8—Dexamethasone—rheumatoid arthritis	0.0045	0.0155	CbGbCtD
Erlotinib—CYP2D6—Cyclosporine—rheumatoid arthritis	0.00436	0.015	CbGbCtD
Erlotinib—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00366	0.0126	CbGbCtD
Erlotinib—CYP3A4—Betamethasone—rheumatoid arthritis	0.00314	0.0108	CbGbCtD
Erlotinib—CYP3A4—Prednisolone—rheumatoid arthritis	0.00309	0.0106	CbGbCtD
Erlotinib—ABCB1—Dexamethasone—rheumatoid arthritis	0.00304	0.0105	CbGbCtD
Erlotinib—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00293	0.0101	CbGbCtD
Erlotinib—CYP3A4—Prednisone—rheumatoid arthritis	0.00292	0.0101	CbGbCtD
Erlotinib—CYP2D6—Dexamethasone—rheumatoid arthritis	0.00287	0.00987	CbGbCtD
Erlotinib—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00277	0.00953	CbGbCtD
Erlotinib—ABCB1—Methotrexate—rheumatoid arthritis	0.00245	0.00842	CbGbCtD
Erlotinib—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00182	0.00628	CbGbCtD
Erlotinib—Gefitinib—IRAK1—rheumatoid arthritis	0.00167	0.493	CrCbGaD
Erlotinib—ORM1—saliva—rheumatoid arthritis	0.00151	0.0705	CbGeAlD
Erlotinib—Vandetanib—BLK—rheumatoid arthritis	0.000948	0.28	CrCbGaD
Erlotinib—JAK3—connective tissue—rheumatoid arthritis	0.000913	0.0427	CbGeAlD
Erlotinib—NR1I2—digestive system—rheumatoid arthritis	0.000825	0.0386	CbGeAlD
Erlotinib—PIP4K2C—parotid gland—rheumatoid arthritis	0.000739	0.0346	CbGeAlD
Erlotinib—FLT3—connective tissue—rheumatoid arthritis	0.00072	0.0337	CbGeAlD
Erlotinib—PIP4K2C—saliva-secreting gland—rheumatoid arthritis	0.000708	0.0331	CbGeAlD
Erlotinib—ULK3—parotid gland—rheumatoid arthritis	0.000706	0.033	CbGeAlD
Erlotinib—AURKC—tendon—rheumatoid arthritis	0.000678	0.0317	CbGeAlD
Erlotinib—ULK3—saliva-secreting gland—rheumatoid arthritis	0.000676	0.0316	CbGeAlD
Erlotinib—JAK3—lymphoid tissue—rheumatoid arthritis	0.000668	0.0312	CbGeAlD
Erlotinib—JAK3—digestive system—rheumatoid arthritis	0.000659	0.0308	CbGeAlD
Erlotinib—SLK—parotid gland—rheumatoid arthritis	0.000629	0.0294	CbGeAlD
Erlotinib—SLK—saliva-secreting gland—rheumatoid arthritis	0.000603	0.0282	CbGeAlD
Erlotinib—TNK1—tendon—rheumatoid arthritis	0.000576	0.027	CbGeAlD
Erlotinib—FLT3—lymphoid tissue—rheumatoid arthritis	0.000527	0.0246	CbGeAlD
Erlotinib—Vandetanib—VEGFA—rheumatoid arthritis	0.000504	0.149	CrCbGaD
Erlotinib—MAP2K5—parotid gland—rheumatoid arthritis	0.000489	0.0229	CbGeAlD
Erlotinib—ABL2—tendon—rheumatoid arthritis	0.000473	0.0221	CbGeAlD
Erlotinib—MAP2K5—saliva-secreting gland—rheumatoid arthritis	0.000468	0.0219	CbGeAlD
Erlotinib—ULK3—digestive system—rheumatoid arthritis	0.000449	0.021	CbGeAlD
Erlotinib—PIP4K2C—tendon—rheumatoid arthritis	0.000447	0.0209	CbGeAlD
Erlotinib—MKNK1—lymphoid tissue—rheumatoid arthritis	0.000428	0.02	CbGeAlD
Erlotinib—ULK3—tendon—rheumatoid arthritis	0.000427	0.02	CbGeAlD
Erlotinib—MKNK1—digestive system—rheumatoid arthritis	0.000422	0.0198	CbGeAlD
Erlotinib—SLK—tendon—rheumatoid arthritis	0.000381	0.0178	CbGeAlD
Erlotinib—ABL1—parotid gland—rheumatoid arthritis	0.000377	0.0176	CbGeAlD
Erlotinib—ABL1—saliva-secreting gland—rheumatoid arthritis	0.000361	0.0169	CbGeAlD
Erlotinib—STK10—lymphoid tissue—rheumatoid arthritis	0.000352	0.0165	CbGeAlD
Erlotinib—STK10—digestive system—rheumatoid arthritis	0.000348	0.0163	CbGeAlD
Erlotinib—ABL1—connective tissue—rheumatoid arthritis	0.000332	0.0155	CbGeAlD
Erlotinib—STK10—tendon—rheumatoid arthritis	0.000331	0.0155	CbGeAlD
Erlotinib—UGT1A1—digestive system—rheumatoid arthritis	0.000328	0.0154	CbGeAlD
Erlotinib—MAP2K5—tendon—rheumatoid arthritis	0.000296	0.0138	CbGeAlD
Erlotinib—CYP1B1—connective tissue—rheumatoid arthritis	0.000281	0.0131	CbGeAlD
Erlotinib—ABL1—lymphoid tissue—rheumatoid arthritis	0.000243	0.0113	CbGeAlD
Erlotinib—SLCO2B1—digestive system—rheumatoid arthritis	0.000242	0.0113	CbGeAlD
Erlotinib—ABL1—digestive system—rheumatoid arthritis	0.00024	0.0112	CbGeAlD
Erlotinib—ABCG2—parotid gland—rheumatoid arthritis	0.000238	0.0111	CbGeAlD
Erlotinib—SLCO2B1—tendon—rheumatoid arthritis	0.00023	0.0108	CbGeAlD
Erlotinib—ABL1—tendon—rheumatoid arthritis	0.000228	0.0107	CbGeAlD
Erlotinib—ABCG2—saliva-secreting gland—rheumatoid arthritis	0.000228	0.0106	CbGeAlD
Erlotinib—CYP1A1—parotid gland—rheumatoid arthritis	0.000226	0.0106	CbGeAlD
Erlotinib—CYP1B1—lymphoid tissue—rheumatoid arthritis	0.000205	0.00961	CbGeAlD
Erlotinib—CYP1B1—digestive system—rheumatoid arthritis	0.000203	0.00949	CbGeAlD
Erlotinib—CYP1B1—tendon—rheumatoid arthritis	0.000193	0.00903	CbGeAlD
Erlotinib—CYP1A2—digestive system—rheumatoid arthritis	0.000145	0.0068	CbGeAlD
Erlotinib—CYP1A1—digestive system—rheumatoid arthritis	0.000143	0.00671	CbGeAlD
Erlotinib—CYP3A5—digestive system—rheumatoid arthritis	0.00014	0.00656	CbGeAlD
Erlotinib—Vandetanib—ALB—rheumatoid arthritis	0.000135	0.04	CrCbGaD
Erlotinib—Gefitinib—ALB—rheumatoid arthritis	0.000129	0.038	CrCbGaD
Erlotinib—CYP3A4—digestive system—rheumatoid arthritis	0.000105	0.00492	CbGeAlD
Erlotinib—CYP2D6—digestive system—rheumatoid arthritis	0.000104	0.00484	CbGeAlD
Erlotinib—ABCB1—lymphoid tissue—rheumatoid arthritis	7.54e-05	0.00353	CbGeAlD
Erlotinib—ABCB1—digestive system—rheumatoid arthritis	7.45e-05	0.00348	CbGeAlD
Erlotinib—Infection—Hydrocortisone—rheumatoid arthritis	6.7e-05	0.000578	CcSEcCtD
Erlotinib—Dyspepsia—Cyclosporine—rheumatoid arthritis	6.68e-05	0.000576	CcSEcCtD
Erlotinib—Shock—Hydrocortisone—rheumatoid arthritis	6.64e-05	0.000572	CcSEcCtD
Erlotinib—Myalgia—Triamcinolone—rheumatoid arthritis	6.63e-05	0.000571	CcSEcCtD
Erlotinib—Vomiting—Azathioprine—rheumatoid arthritis	6.62e-05	0.000571	CcSEcCtD
Erlotinib—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	6.62e-05	0.00057	CcSEcCtD
Erlotinib—Pneumonia—Methotrexate—rheumatoid arthritis	6.62e-05	0.00057	CcSEcCtD
Erlotinib—Myalgia—Methylprednisolone—rheumatoid arthritis	6.61e-05	0.00057	CcSEcCtD
Erlotinib—Arthralgia—Methylprednisolone—rheumatoid arthritis	6.61e-05	0.00057	CcSEcCtD
Erlotinib—Eye disorder—Prednisone—rheumatoid arthritis	6.6e-05	0.000569	CcSEcCtD
Erlotinib—Decreased appetite—Cyclosporine—rheumatoid arthritis	6.6e-05	0.000569	CcSEcCtD
Erlotinib—Anxiety—Methylprednisolone—rheumatoid arthritis	6.59e-05	0.000568	CcSEcCtD
Erlotinib—Infestation NOS—Methotrexate—rheumatoid arthritis	6.58e-05	0.000567	CcSEcCtD
Erlotinib—Infestation—Methotrexate—rheumatoid arthritis	6.58e-05	0.000567	CcSEcCtD
Erlotinib—Rash—Azathioprine—rheumatoid arthritis	6.57e-05	0.000566	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	6.57e-05	0.000566	CcSEcCtD
Erlotinib—Dermatitis—Azathioprine—rheumatoid arthritis	6.56e-05	0.000566	CcSEcCtD
Erlotinib—Depression—Methotrexate—rheumatoid arthritis	6.56e-05	0.000565	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	6.56e-05	0.000565	CcSEcCtD
Erlotinib—Skin disorder—Hydrocortisone—rheumatoid arthritis	6.56e-05	0.000565	CcSEcCtD
Erlotinib—Fatigue—Cyclosporine—rheumatoid arthritis	6.55e-05	0.000564	CcSEcCtD
Erlotinib—Headache—Azathioprine—rheumatoid arthritis	6.53e-05	0.000563	CcSEcCtD
Erlotinib—Stevens-Johnson syndrome—Methotrexate—rheumatoid arthritis	6.52e-05	0.000562	CcSEcCtD
Erlotinib—Dizziness—Leflunomide—rheumatoid arthritis	6.51e-05	0.000561	CcSEcCtD
Erlotinib—Pain—Cyclosporine—rheumatoid arthritis	6.49e-05	0.00056	CcSEcCtD
Erlotinib—Constipation—Cyclosporine—rheumatoid arthritis	6.49e-05	0.00056	CcSEcCtD
Erlotinib—Renal failure—Methotrexate—rheumatoid arthritis	6.47e-05	0.000557	CcSEcCtD
Erlotinib—Anorexia—Hydrocortisone—rheumatoid arthritis	6.43e-05	0.000554	CcSEcCtD
Erlotinib—Stomatitis—Methotrexate—rheumatoid arthritis	6.41e-05	0.000553	CcSEcCtD
Erlotinib—Conjunctivitis—Methotrexate—rheumatoid arthritis	6.4e-05	0.000551	CcSEcCtD
Erlotinib—Oedema—Triamcinolone—rheumatoid arthritis	6.35e-05	0.000548	CcSEcCtD
Erlotinib—Syncope—Dexamethasone—rheumatoid arthritis	6.34e-05	0.000546	CcSEcCtD
Erlotinib—Syncope—Betamethasone—rheumatoid arthritis	6.34e-05	0.000546	CcSEcCtD
Erlotinib—Arrhythmia—Prednisone—rheumatoid arthritis	6.31e-05	0.000544	CcSEcCtD
Erlotinib—Infection—Triamcinolone—rheumatoid arthritis	6.31e-05	0.000544	CcSEcCtD
Erlotinib—Infection—Methylprednisolone—rheumatoid arthritis	6.3e-05	0.000543	CcSEcCtD
Erlotinib—Vomiting—Leflunomide—rheumatoid arthritis	6.26e-05	0.000539	CcSEcCtD
Erlotinib—Shock—Triamcinolone—rheumatoid arthritis	6.25e-05	0.000539	CcSEcCtD
Erlotinib—Insomnia—Prednisolone—rheumatoid arthritis	6.25e-05	0.000539	CcSEcCtD
Erlotinib—Alopecia—Prednisone—rheumatoid arthritis	6.25e-05	0.000538	CcSEcCtD
Erlotinib—Shock—Methylprednisolone—rheumatoid arthritis	6.24e-05	0.000538	CcSEcCtD
Erlotinib—Hepatobiliary disease—Methotrexate—rheumatoid arthritis	6.22e-05	0.000536	CcSEcCtD
Erlotinib—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	6.22e-05	0.000536	CcSEcCtD
Erlotinib—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	6.21e-05	0.000535	CcSEcCtD
Erlotinib—Loss of consciousness—Dexamethasone—rheumatoid arthritis	6.21e-05	0.000535	CcSEcCtD
Erlotinib—Loss of consciousness—Betamethasone—rheumatoid arthritis	6.21e-05	0.000535	CcSEcCtD
Erlotinib—Epistaxis—Methotrexate—rheumatoid arthritis	6.21e-05	0.000535	CcSEcCtD
Erlotinib—Rash—Leflunomide—rheumatoid arthritis	6.2e-05	0.000535	CcSEcCtD
Erlotinib—Dermatitis—Leflunomide—rheumatoid arthritis	6.2e-05	0.000534	CcSEcCtD
Erlotinib—Mental disorder—Prednisone—rheumatoid arthritis	6.19e-05	0.000534	CcSEcCtD
Erlotinib—Nausea—Azathioprine—rheumatoid arthritis	6.19e-05	0.000533	CcSEcCtD
Erlotinib—Headache—Leflunomide—rheumatoid arthritis	6.16e-05	0.000531	CcSEcCtD
Erlotinib—Skin disorder—Methylprednisolone—rheumatoid arthritis	6.16e-05	0.000531	CcSEcCtD
Erlotinib—Malnutrition—Prednisone—rheumatoid arthritis	6.15e-05	0.00053	CcSEcCtD
Erlotinib—Erythema—Prednisone—rheumatoid arthritis	6.15e-05	0.00053	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	6.15e-05	0.00053	CcSEcCtD
Erlotinib—Insomnia—Hydrocortisone—rheumatoid arthritis	6.1e-05	0.000526	CcSEcCtD
Erlotinib—Myalgia—Betamethasone—rheumatoid arthritis	6.01e-05	0.000518	CcSEcCtD
Erlotinib—Myalgia—Dexamethasone—rheumatoid arthritis	6.01e-05	0.000518	CcSEcCtD
Erlotinib—Body temperature increased—Cyclosporine—rheumatoid arthritis	6e-05	0.000517	CcSEcCtD
Erlotinib—Abdominal pain—Cyclosporine—rheumatoid arthritis	6e-05	0.000517	CcSEcCtD
Erlotinib—Anxiety—Dexamethasone—rheumatoid arthritis	5.99e-05	0.000517	CcSEcCtD
Erlotinib—Anxiety—Betamethasone—rheumatoid arthritis	5.99e-05	0.000517	CcSEcCtD
Erlotinib—Dyspepsia—Hydrocortisone—rheumatoid arthritis	5.94e-05	0.000512	CcSEcCtD
Erlotinib—Haemoglobin—Methotrexate—rheumatoid arthritis	5.94e-05	0.000512	CcSEcCtD
Erlotinib—Pain—Prednisolone—rheumatoid arthritis	5.91e-05	0.000509	CcSEcCtD
Erlotinib—Haemorrhage—Methotrexate—rheumatoid arthritis	5.91e-05	0.000509	CcSEcCtD
Erlotinib—Hepatitis—Methotrexate—rheumatoid arthritis	5.91e-05	0.000509	CcSEcCtD
Erlotinib—Decreased appetite—Hydrocortisone—rheumatoid arthritis	5.87e-05	0.000506	CcSEcCtD
Erlotinib—Nausea—Leflunomide—rheumatoid arthritis	5.84e-05	0.000504	CcSEcCtD
Erlotinib—Urinary tract disorder—Methotrexate—rheumatoid arthritis	5.83e-05	0.000503	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	5.83e-05	0.000502	CcSEcCtD
Erlotinib—Fatigue—Hydrocortisone—rheumatoid arthritis	5.82e-05	0.000501	CcSEcCtD
Erlotinib—Urethral disorder—Methotrexate—rheumatoid arthritis	5.79e-05	0.000499	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	5.79e-05	0.000499	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	5.78e-05	0.000498	CcSEcCtD
Erlotinib—Pain—Hydrocortisone—rheumatoid arthritis	5.77e-05	0.000497	CcSEcCtD
Erlotinib—Oedema—Dexamethasone—rheumatoid arthritis	5.77e-05	0.000497	CcSEcCtD
Erlotinib—Oedema—Betamethasone—rheumatoid arthritis	5.77e-05	0.000497	CcSEcCtD
Erlotinib—Insomnia—Triamcinolone—rheumatoid arthritis	5.75e-05	0.000495	CcSEcCtD
Erlotinib—Insomnia—Methylprednisolone—rheumatoid arthritis	5.73e-05	0.000494	CcSEcCtD
Erlotinib—Infection—Dexamethasone—rheumatoid arthritis	5.73e-05	0.000494	CcSEcCtD
Erlotinib—Infection—Betamethasone—rheumatoid arthritis	5.73e-05	0.000494	CcSEcCtD
Erlotinib—Shock—Betamethasone—rheumatoid arthritis	5.67e-05	0.000489	CcSEcCtD
Erlotinib—Shock—Dexamethasone—rheumatoid arthritis	5.67e-05	0.000489	CcSEcCtD
Erlotinib—Dyspnoea—Triamcinolone—rheumatoid arthritis	5.67e-05	0.000488	CcSEcCtD
Erlotinib—Nervous system disorder—Dexamethasone—rheumatoid arthritis	5.65e-05	0.000487	CcSEcCtD
Erlotinib—Nervous system disorder—Betamethasone—rheumatoid arthritis	5.65e-05	0.000487	CcSEcCtD
Erlotinib—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	5.65e-05	0.000487	CcSEcCtD
Erlotinib—Thrombocytopenia—Betamethasone—rheumatoid arthritis	5.65e-05	0.000487	CcSEcCtD
Erlotinib—Dyspepsia—Triamcinolone—rheumatoid arthritis	5.59e-05	0.000482	CcSEcCtD
Erlotinib—Erythema multiforme—Methotrexate—rheumatoid arthritis	5.58e-05	0.000481	CcSEcCtD
Erlotinib—Dyspepsia—Methylprednisolone—rheumatoid arthritis	5.58e-05	0.000481	CcSEcCtD
Erlotinib—Eye disorder—Methotrexate—rheumatoid arthritis	5.52e-05	0.000476	CcSEcCtD
Erlotinib—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	5.52e-05	0.000476	CcSEcCtD
Erlotinib—Syncope—Prednisone—rheumatoid arthritis	5.52e-05	0.000476	CcSEcCtD
Erlotinib—Anorexia—Betamethasone—rheumatoid arthritis	5.5e-05	0.000474	CcSEcCtD
Erlotinib—Anorexia—Dexamethasone—rheumatoid arthritis	5.5e-05	0.000474	CcSEcCtD
Erlotinib—Fatigue—Triamcinolone—rheumatoid arthritis	5.48e-05	0.000472	CcSEcCtD
Erlotinib—Fatigue—Methylprednisolone—rheumatoid arthritis	5.47e-05	0.000471	CcSEcCtD
Erlotinib—Asthenia—Cyclosporine—rheumatoid arthritis	5.45e-05	0.00047	CcSEcCtD
Erlotinib—Pain—Triamcinolone—rheumatoid arthritis	5.43e-05	0.000468	CcSEcCtD
Erlotinib—Loss of consciousness—Prednisone—rheumatoid arthritis	5.41e-05	0.000466	CcSEcCtD
Erlotinib—Pruritus—Cyclosporine—rheumatoid arthritis	5.37e-05	0.000463	CcSEcCtD
Erlotinib—Body temperature increased—Hydrocortisone—rheumatoid arthritis	5.33e-05	0.00046	CcSEcCtD
Erlotinib—Abdominal pain—Hydrocortisone—rheumatoid arthritis	5.33e-05	0.00046	CcSEcCtD
Erlotinib—Mediastinal disorder—Methotrexate—rheumatoid arthritis	5.32e-05	0.000459	CcSEcCtD
Erlotinib—Chills—Methotrexate—rheumatoid arthritis	5.3e-05	0.000457	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	5.25e-05	0.000453	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	5.25e-05	0.000453	CcSEcCtD
Erlotinib—Arthralgia—Prednisone—rheumatoid arthritis	5.24e-05	0.000451	CcSEcCtD
Erlotinib—Myalgia—Prednisone—rheumatoid arthritis	5.24e-05	0.000451	CcSEcCtD
Erlotinib—Anxiety—Prednisone—rheumatoid arthritis	5.22e-05	0.00045	CcSEcCtD
Erlotinib—Alopecia—Methotrexate—rheumatoid arthritis	5.22e-05	0.00045	CcSEcCtD
Erlotinib—Insomnia—Dexamethasone—rheumatoid arthritis	5.21e-05	0.000449	CcSEcCtD
Erlotinib—Insomnia—Betamethasone—rheumatoid arthritis	5.21e-05	0.000449	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	5.2e-05	0.000448	CcSEcCtD
Erlotinib—Diarrhoea—Cyclosporine—rheumatoid arthritis	5.2e-05	0.000448	CcSEcCtD
Erlotinib—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	5.18e-05	0.000447	CcSEcCtD
Erlotinib—Mental disorder—Methotrexate—rheumatoid arthritis	5.17e-05	0.000446	CcSEcCtD
Erlotinib—Malnutrition—Methotrexate—rheumatoid arthritis	5.14e-05	0.000443	CcSEcCtD
Erlotinib—Erythema—Methotrexate—rheumatoid arthritis	5.14e-05	0.000443	CcSEcCtD
Erlotinib—Dyspepsia—Dexamethasone—rheumatoid arthritis	5.08e-05	0.000437	CcSEcCtD
Erlotinib—Dyspepsia—Betamethasone—rheumatoid arthritis	5.08e-05	0.000437	CcSEcCtD
Erlotinib—Body temperature increased—Triamcinolone—rheumatoid arthritis	5.02e-05	0.000433	CcSEcCtD
Erlotinib—Dizziness—Cyclosporine—rheumatoid arthritis	5.02e-05	0.000433	CcSEcCtD
Erlotinib—Oedema—Prednisone—rheumatoid arthritis	5.02e-05	0.000433	CcSEcCtD
Erlotinib—Abdominal pain—Methylprednisolone—rheumatoid arthritis	5.01e-05	0.000432	CcSEcCtD
Erlotinib—Decreased appetite—Betamethasone—rheumatoid arthritis	5.01e-05	0.000432	CcSEcCtD
Erlotinib—Decreased appetite—Dexamethasone—rheumatoid arthritis	5.01e-05	0.000432	CcSEcCtD
Erlotinib—Infection—Prednisone—rheumatoid arthritis	4.99e-05	0.00043	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	4.98e-05	0.000429	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	4.98e-05	0.000429	CcSEcCtD
Erlotinib—Back pain—Methotrexate—rheumatoid arthritis	4.97e-05	0.000429	CcSEcCtD
Erlotinib—Fatigue—Dexamethasone—rheumatoid arthritis	4.97e-05	0.000428	CcSEcCtD
Erlotinib—Fatigue—Betamethasone—rheumatoid arthritis	4.97e-05	0.000428	CcSEcCtD
Erlotinib—Shock—Prednisone—rheumatoid arthritis	4.94e-05	0.000426	CcSEcCtD
Erlotinib—Pain—Betamethasone—rheumatoid arthritis	4.93e-05	0.000425	CcSEcCtD
Erlotinib—Pain—Dexamethasone—rheumatoid arthritis	4.93e-05	0.000425	CcSEcCtD
Erlotinib—Nervous system disorder—Prednisone—rheumatoid arthritis	4.92e-05	0.000424	CcSEcCtD
Erlotinib—Skin disorder—Prednisone—rheumatoid arthritis	4.88e-05	0.00042	CcSEcCtD
Erlotinib—Asthenia—Hydrocortisone—rheumatoid arthritis	4.84e-05	0.000417	CcSEcCtD
Erlotinib—Vomiting—Cyclosporine—rheumatoid arthritis	4.83e-05	0.000416	CcSEcCtD
Erlotinib—Rash—Cyclosporine—rheumatoid arthritis	4.79e-05	0.000413	CcSEcCtD
Erlotinib—Anorexia—Prednisone—rheumatoid arthritis	4.79e-05	0.000413	CcSEcCtD
Erlotinib—Dermatitis—Cyclosporine—rheumatoid arthritis	4.78e-05	0.000412	CcSEcCtD
Erlotinib—Pruritus—Hydrocortisone—rheumatoid arthritis	4.77e-05	0.000412	CcSEcCtD
Erlotinib—Headache—Cyclosporine—rheumatoid arthritis	4.76e-05	0.00041	CcSEcCtD
Erlotinib—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	4.71e-05	0.000406	CcSEcCtD
Erlotinib—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	4.71e-05	0.000406	CcSEcCtD
Erlotinib—Diarrhoea—Hydrocortisone—rheumatoid arthritis	4.62e-05	0.000398	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	4.57e-05	0.000394	CcSEcCtD
Erlotinib—Dizziness—Prednisolone—rheumatoid arthritis	4.57e-05	0.000394	CcSEcCtD
Erlotinib—Asthenia—Triamcinolone—rheumatoid arthritis	4.56e-05	0.000393	CcSEcCtD
Erlotinib—Abdominal pain—Betamethasone—rheumatoid arthritis	4.56e-05	0.000393	CcSEcCtD
Erlotinib—Abdominal pain—Dexamethasone—rheumatoid arthritis	4.56e-05	0.000393	CcSEcCtD
Erlotinib—Body temperature increased—Betamethasone—rheumatoid arthritis	4.56e-05	0.000393	CcSEcCtD
Erlotinib—Body temperature increased—Dexamethasone—rheumatoid arthritis	4.56e-05	0.000393	CcSEcCtD
Erlotinib—Asthenia—Methylprednisolone—rheumatoid arthritis	4.55e-05	0.000392	CcSEcCtD
Erlotinib—Insomnia—Prednisone—rheumatoid arthritis	4.54e-05	0.000391	CcSEcCtD
Erlotinib—Nausea—Cyclosporine—rheumatoid arthritis	4.51e-05	0.000389	CcSEcCtD
Erlotinib—Pruritus—Triamcinolone—rheumatoid arthritis	4.5e-05	0.000387	CcSEcCtD
Erlotinib—Cough—Methotrexate—rheumatoid arthritis	4.49e-05	0.000387	CcSEcCtD
Erlotinib—Pruritus—Methylprednisolone—rheumatoid arthritis	4.49e-05	0.000387	CcSEcCtD
Erlotinib—Dizziness—Hydrocortisone—rheumatoid arthritis	4.46e-05	0.000385	CcSEcCtD
Erlotinib—Dyspepsia—Prednisone—rheumatoid arthritis	4.42e-05	0.000381	CcSEcCtD
Erlotinib—Myalgia—Methotrexate—rheumatoid arthritis	4.38e-05	0.000377	CcSEcCtD
Erlotinib—Arthralgia—Methotrexate—rheumatoid arthritis	4.38e-05	0.000377	CcSEcCtD
Erlotinib—Chest pain—Methotrexate—rheumatoid arthritis	4.38e-05	0.000377	CcSEcCtD
Erlotinib—Decreased appetite—Prednisone—rheumatoid arthritis	4.36e-05	0.000376	CcSEcCtD
Erlotinib—Rash—Prednisolone—rheumatoid arthritis	4.36e-05	0.000376	CcSEcCtD
Erlotinib—Dermatitis—Prednisolone—rheumatoid arthritis	4.35e-05	0.000375	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	4.35e-05	0.000375	CcSEcCtD
Erlotinib—Diarrhoea—Methylprednisolone—rheumatoid arthritis	4.34e-05	0.000374	CcSEcCtD
Erlotinib—Fatigue—Prednisone—rheumatoid arthritis	4.33e-05	0.000373	CcSEcCtD
Erlotinib—Headache—Prednisolone—rheumatoid arthritis	4.33e-05	0.000373	CcSEcCtD
Erlotinib—Constipation—Prednisone—rheumatoid arthritis	4.29e-05	0.00037	CcSEcCtD
Erlotinib—Vomiting—Hydrocortisone—rheumatoid arthritis	4.29e-05	0.00037	CcSEcCtD
Erlotinib—Rash—Hydrocortisone—rheumatoid arthritis	4.26e-05	0.000367	CcSEcCtD
Erlotinib—Dermatitis—Hydrocortisone—rheumatoid arthritis	4.25e-05	0.000366	CcSEcCtD
Erlotinib—Headache—Hydrocortisone—rheumatoid arthritis	4.23e-05	0.000364	CcSEcCtD
Erlotinib—Dizziness—Triamcinolone—rheumatoid arthritis	4.2e-05	0.000362	CcSEcCtD
Erlotinib—Dizziness—Methylprednisolone—rheumatoid arthritis	4.19e-05	0.000361	CcSEcCtD
Erlotinib—Infection—Methotrexate—rheumatoid arthritis	4.17e-05	0.000359	CcSEcCtD
Erlotinib—Asthenia—Dexamethasone—rheumatoid arthritis	4.14e-05	0.000357	CcSEcCtD
Erlotinib—Asthenia—Betamethasone—rheumatoid arthritis	4.14e-05	0.000357	CcSEcCtD
Erlotinib—Nervous system disorder—Methotrexate—rheumatoid arthritis	4.12e-05	0.000355	CcSEcCtD
Erlotinib—Thrombocytopenia—Methotrexate—rheumatoid arthritis	4.11e-05	0.000354	CcSEcCtD
Erlotinib—Gastrointestinal pain—Prednisone—rheumatoid arthritis	4.11e-05	0.000354	CcSEcCtD
Erlotinib—Nausea—Prednisolone—rheumatoid arthritis	4.1e-05	0.000354	CcSEcCtD
Erlotinib—Pruritus—Betamethasone—rheumatoid arthritis	4.08e-05	0.000352	CcSEcCtD
Erlotinib—Pruritus—Dexamethasone—rheumatoid arthritis	4.08e-05	0.000352	CcSEcCtD
Erlotinib—Skin disorder—Methotrexate—rheumatoid arthritis	4.08e-05	0.000351	CcSEcCtD
Erlotinib—Vomiting—Triamcinolone—rheumatoid arthritis	4.04e-05	0.000348	CcSEcCtD
Erlotinib—Vomiting—Methylprednisolone—rheumatoid arthritis	4.03e-05	0.000347	CcSEcCtD
Erlotinib—Nausea—Hydrocortisone—rheumatoid arthritis	4.01e-05	0.000346	CcSEcCtD
Erlotinib—Rash—Triamcinolone—rheumatoid arthritis	4.01e-05	0.000345	CcSEcCtD
Erlotinib—Dermatitis—Triamcinolone—rheumatoid arthritis	4e-05	0.000345	CcSEcCtD
Erlotinib—Anorexia—Methotrexate—rheumatoid arthritis	4e-05	0.000345	CcSEcCtD
Erlotinib—Rash—Methylprednisolone—rheumatoid arthritis	4e-05	0.000345	CcSEcCtD
Erlotinib—Dermatitis—Methylprednisolone—rheumatoid arthritis	3.99e-05	0.000344	CcSEcCtD
Erlotinib—Headache—Triamcinolone—rheumatoid arthritis	3.98e-05	0.000343	CcSEcCtD
Erlotinib—Headache—Methylprednisolone—rheumatoid arthritis	3.97e-05	0.000342	CcSEcCtD
Erlotinib—Body temperature increased—Prednisone—rheumatoid arthritis	3.97e-05	0.000342	CcSEcCtD
Erlotinib—Abdominal pain—Prednisone—rheumatoid arthritis	3.97e-05	0.000342	CcSEcCtD
Erlotinib—Diarrhoea—Dexamethasone—rheumatoid arthritis	3.95e-05	0.00034	CcSEcCtD
Erlotinib—Diarrhoea—Betamethasone—rheumatoid arthritis	3.95e-05	0.00034	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	3.82e-05	0.00033	CcSEcCtD
Erlotinib—Dizziness—Betamethasone—rheumatoid arthritis	3.81e-05	0.000329	CcSEcCtD
Erlotinib—Dizziness—Dexamethasone—rheumatoid arthritis	3.81e-05	0.000329	CcSEcCtD
Erlotinib—Insomnia—Methotrexate—rheumatoid arthritis	3.8e-05	0.000327	CcSEcCtD
Erlotinib—Nausea—Triamcinolone—rheumatoid arthritis	3.77e-05	0.000325	CcSEcCtD
Erlotinib—Nausea—Methylprednisolone—rheumatoid arthritis	3.77e-05	0.000325	CcSEcCtD
Erlotinib—Dyspnoea—Methotrexate—rheumatoid arthritis	3.74e-05	0.000322	CcSEcCtD
Erlotinib—Dyspepsia—Methotrexate—rheumatoid arthritis	3.69e-05	0.000318	CcSEcCtD
Erlotinib—Vomiting—Dexamethasone—rheumatoid arthritis	3.67e-05	0.000316	CcSEcCtD
Erlotinib—Vomiting—Betamethasone—rheumatoid arthritis	3.67e-05	0.000316	CcSEcCtD
Erlotinib—Decreased appetite—Methotrexate—rheumatoid arthritis	3.65e-05	0.000314	CcSEcCtD
Erlotinib—Rash—Dexamethasone—rheumatoid arthritis	3.64e-05	0.000313	CcSEcCtD
Erlotinib—Rash—Betamethasone—rheumatoid arthritis	3.64e-05	0.000313	CcSEcCtD
Erlotinib—Dermatitis—Dexamethasone—rheumatoid arthritis	3.63e-05	0.000313	CcSEcCtD
Erlotinib—Dermatitis—Betamethasone—rheumatoid arthritis	3.63e-05	0.000313	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	3.62e-05	0.000312	CcSEcCtD
Erlotinib—Fatigue—Methotrexate—rheumatoid arthritis	3.62e-05	0.000312	CcSEcCtD
Erlotinib—Headache—Dexamethasone—rheumatoid arthritis	3.61e-05	0.000311	CcSEcCtD
Erlotinib—Headache—Betamethasone—rheumatoid arthritis	3.61e-05	0.000311	CcSEcCtD
Erlotinib—Asthenia—Prednisone—rheumatoid arthritis	3.6e-05	0.000311	CcSEcCtD
Erlotinib—Pain—Methotrexate—rheumatoid arthritis	3.59e-05	0.000309	CcSEcCtD
Erlotinib—Pruritus—Prednisone—rheumatoid arthritis	3.55e-05	0.000306	CcSEcCtD
Erlotinib—Diarrhoea—Prednisone—rheumatoid arthritis	3.44e-05	0.000296	CcSEcCtD
Erlotinib—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	3.43e-05	0.000296	CcSEcCtD
Erlotinib—Nausea—Dexamethasone—rheumatoid arthritis	3.42e-05	0.000295	CcSEcCtD
Erlotinib—Nausea—Betamethasone—rheumatoid arthritis	3.42e-05	0.000295	CcSEcCtD
Erlotinib—Dizziness—Prednisone—rheumatoid arthritis	3.32e-05	0.000286	CcSEcCtD
Erlotinib—Abdominal pain—Methotrexate—rheumatoid arthritis	3.32e-05	0.000286	CcSEcCtD
Erlotinib—Body temperature increased—Methotrexate—rheumatoid arthritis	3.32e-05	0.000286	CcSEcCtD
Erlotinib—Vomiting—Prednisone—rheumatoid arthritis	3.19e-05	0.000275	CcSEcCtD
Erlotinib—Rash—Prednisone—rheumatoid arthritis	3.17e-05	0.000273	CcSEcCtD
Erlotinib—Dermatitis—Prednisone—rheumatoid arthritis	3.16e-05	0.000273	CcSEcCtD
Erlotinib—Headache—Prednisone—rheumatoid arthritis	3.15e-05	0.000271	CcSEcCtD
Erlotinib—Asthenia—Methotrexate—rheumatoid arthritis	3.01e-05	0.00026	CcSEcCtD
Erlotinib—Nausea—Prednisone—rheumatoid arthritis	2.98e-05	0.000257	CcSEcCtD
Erlotinib—Pruritus—Methotrexate—rheumatoid arthritis	2.97e-05	0.000256	CcSEcCtD
Erlotinib—Diarrhoea—Methotrexate—rheumatoid arthritis	2.87e-05	0.000247	CcSEcCtD
Erlotinib—Dizziness—Methotrexate—rheumatoid arthritis	2.78e-05	0.000239	CcSEcCtD
Erlotinib—Vomiting—Methotrexate—rheumatoid arthritis	2.67e-05	0.00023	CcSEcCtD
Erlotinib—Rash—Methotrexate—rheumatoid arthritis	2.65e-05	0.000228	CcSEcCtD
Erlotinib—Dermatitis—Methotrexate—rheumatoid arthritis	2.64e-05	0.000228	CcSEcCtD
Erlotinib—Headache—Methotrexate—rheumatoid arthritis	2.63e-05	0.000227	CcSEcCtD
Erlotinib—Nausea—Methotrexate—rheumatoid arthritis	2.49e-05	0.000215	CcSEcCtD
Erlotinib—EGFR—Immune System—HLA-A—rheumatoid arthritis	4.35e-06	5.45e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—BGN—rheumatoid arthritis	4.34e-06	5.43e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—BGN—rheumatoid arthritis	4.31e-06	5.4e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD80—rheumatoid arthritis	4.3e-06	5.38e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—VEGFA—rheumatoid arthritis	4.3e-06	5.38e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—UBE2D1—rheumatoid arthritis	4.3e-06	5.38e-05	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—TGFB1—rheumatoid arthritis	4.29e-06	5.37e-05	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—TNF—rheumatoid arthritis	4.28e-06	5.35e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—VEGFA—rheumatoid arthritis	4.26e-06	5.34e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—MED1—rheumatoid arthritis	4.25e-06	5.33e-05	CbGpPWpGaD
Erlotinib—MKNK1—Disease—IL6—rheumatoid arthritis	4.24e-06	5.31e-05	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	4.22e-06	5.29e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—BDKRB2—rheumatoid arthritis	4.21e-06	5.27e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CXCL12—rheumatoid arthritis	4.21e-06	5.27e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—FN1—rheumatoid arthritis	4.21e-06	5.27e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—POMC—rheumatoid arthritis	4.2e-06	5.26e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—B3GNT2—rheumatoid arthritis	4.2e-06	5.25e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ACP5—rheumatoid arthritis	4.2e-06	5.25e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL6ST—rheumatoid arthritis	4.18e-06	5.23e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—ADRBK1—rheumatoid arthritis	4.17e-06	5.21e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—NOS2—rheumatoid arthritis	4.16e-06	5.21e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CRP—rheumatoid arthritis	4.15e-06	5.2e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CAT—rheumatoid arthritis	4.15e-06	5.19e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—NFKB1—rheumatoid arthritis	4.15e-06	5.19e-05	CbGpPWpGaD
Erlotinib—EGFR—Axon guidance—IL6—rheumatoid arthritis	4.13e-06	5.17e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—CCR5—rheumatoid arthritis	4.12e-06	5.16e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CCL2—rheumatoid arthritis	4.11e-06	5.15e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PLB1—rheumatoid arthritis	4.11e-06	5.14e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL6R—rheumatoid arthritis	4.1e-06	5.13e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—MAPK8—rheumatoid arthritis	4.08e-06	5.1e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—MTHFR—rheumatoid arthritis	4.03e-06	5.04e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—HLA-A—rheumatoid arthritis	4.02e-06	5.03e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ALOX5—rheumatoid arthritis	3.99e-06	5e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CXCL8—rheumatoid arthritis	3.99e-06	4.99e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL6R—rheumatoid arthritis	3.98e-06	4.99e-05	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—NFKB1—rheumatoid arthritis	3.98e-06	4.99e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—TLR4—rheumatoid arthritis	3.98e-06	4.98e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—HLA-DRB1—rheumatoid arthritis	3.98e-06	4.98e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ALOX5—rheumatoid arthritis	3.97e-06	4.97e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ACP5—rheumatoid arthritis	3.95e-06	4.95e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—B3GNT2—rheumatoid arthritis	3.95e-06	4.95e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—TGFB1—rheumatoid arthritis	3.94e-06	4.94e-05	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	3.94e-06	4.94e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—RASGRP1—rheumatoid arthritis	3.93e-06	4.92e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—SYK—rheumatoid arthritis	3.92e-06	4.9e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—TGFB1—rheumatoid arthritis	3.91e-06	4.9e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PLD4—rheumatoid arthritis	3.86e-06	4.84e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PRKCQ—rheumatoid arthritis	3.84e-06	4.81e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.83e-06	4.79e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—POMC—rheumatoid arthritis	3.82e-06	4.78e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—ICAM1—rheumatoid arthritis	3.82e-06	4.78e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL6ST—rheumatoid arthritis	3.82e-06	4.78e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—IL2—rheumatoid arthritis	3.81e-06	4.77e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—IL6—rheumatoid arthritis	3.79e-06	4.75e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—BGN—rheumatoid arthritis	3.78e-06	4.73e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—STAT1—rheumatoid arthritis	3.78e-06	4.73e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CAT—rheumatoid arthritis	3.77e-06	4.72e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ENO1—rheumatoid arthritis	3.76e-06	4.7e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CCL2—rheumatoid arthritis	3.74e-06	4.68e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TYK2—rheumatoid arthritis	3.74e-06	4.68e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ACAN—rheumatoid arthritis	3.73e-06	4.67e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL6R—rheumatoid arthritis	3.73e-06	4.66e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CXCL10—rheumatoid arthritis	3.72e-06	4.66e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—MTHFR—rheumatoid arthritis	3.71e-06	4.65e-05	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—TP53—rheumatoid arthritis	3.7e-06	4.63e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD80—rheumatoid arthritis	3.67e-06	4.6e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—NOS3—rheumatoid arthritis	3.67e-06	4.59e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—TNF—rheumatoid arthritis	3.65e-06	4.57e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—TYK2—rheumatoid arthritis	3.63e-06	4.54e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—MMP9—rheumatoid arthritis	3.61e-06	4.52e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—MED1—rheumatoid arthritis	3.6e-06	4.51e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—NFKB1—rheumatoid arthritis	3.57e-06	4.47e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—BGN—rheumatoid arthritis	3.56e-06	4.46e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ENO1—rheumatoid arthritis	3.55e-06	4.44e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—IL6ST—rheumatoid arthritis	3.52e-06	4.41e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.51e-06	4.39e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—MAPK8—rheumatoid arthritis	3.51e-06	4.39e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SLC25A12—rheumatoid arthritis	3.51e-06	4.39e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—NOS2—rheumatoid arthritis	3.5e-06	4.38e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	3.49e-06	4.37e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	3.49e-06	4.37e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ALOX5—rheumatoid arthritis	3.48e-06	4.35e-05	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	3.48e-06	4.35e-05	CbGpPWpGaD
Erlotinib—JAK3—Immune System—IL6—rheumatoid arthritis	3.47e-06	4.34e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—MTHFR—rheumatoid arthritis	3.46e-06	4.33e-05	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—IL6—rheumatoid arthritis	3.45e-06	4.32e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GC—rheumatoid arthritis	3.41e-06	4.27e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	3.41e-06	4.27e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL6R—rheumatoid arthritis	3.4e-06	4.26e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IFNG—rheumatoid arthritis	3.4e-06	4.25e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MMP3—rheumatoid arthritis	3.4e-06	4.25e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—TYK2—rheumatoid arthritis	3.39e-06	4.25e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—CD80—rheumatoid arthritis	3.39e-06	4.25e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—B3GNT2—rheumatoid arthritis	3.35e-06	4.19e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ACP5—rheumatoid arthritis	3.35e-06	4.19e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—NOS3—rheumatoid arthritis	3.34e-06	4.19e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD4—rheumatoid arthritis	3.28e-06	4.11e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ALOX5—rheumatoid arthritis	3.28e-06	4.1e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—PTK2—rheumatoid arthritis	3.27e-06	4.09e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ENO1—rheumatoid arthritis	3.25e-06	4.07e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CXCL8—rheumatoid arthritis	3.25e-06	4.07e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—TP53—rheumatoid arthritis	3.25e-06	4.06e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—VEGFA—rheumatoid arthritis	3.24e-06	4.06e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ENO1—rheumatoid arthritis	3.24e-06	4.05e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCL5—rheumatoid arthritis	3.2e-06	4.01e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	3.2e-06	4.01e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	3.17e-06	3.97e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CSF2—rheumatoid arthritis	3.16e-06	3.95e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—MTHFR—rheumatoid arthritis	3.15e-06	3.94e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—IL6R—rheumatoid arthritis	3.14e-06	3.93e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL2—rheumatoid arthritis	3.11e-06	3.89e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—TYK2—rheumatoid arthritis	3.1e-06	3.88e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	3.05e-06	3.82e-05	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—IL6—rheumatoid arthritis	3.05e-06	3.81e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL1B—rheumatoid arthritis	3.03e-06	3.79e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL2—rheumatoid arthritis	3.02e-06	3.78e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—BGN—rheumatoid arthritis	3.02e-06	3.78e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TGFB1—rheumatoid arthritis	2.97e-06	3.72e-05	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—IL6—rheumatoid arthritis	2.97e-06	3.72e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—POMC—rheumatoid arthritis	2.97e-06	3.72e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—SPP1—rheumatoid arthritis	2.97e-06	3.72e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CXCL8—rheumatoid arthritis	2.95e-06	3.7e-05	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—IL6—rheumatoid arthritis	2.95e-06	3.69e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—MMP9—rheumatoid arthritis	2.94e-06	3.68e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—NFKB1—rheumatoid arthritis	2.91e-06	3.64e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IFNG—rheumatoid arthritis	2.9e-06	3.63e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCR5—rheumatoid arthritis	2.89e-06	3.61e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—TYK2—rheumatoid arthritis	2.86e-06	3.58e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—MAPK8—rheumatoid arthritis	2.86e-06	3.58e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL2RA—rheumatoid arthritis	2.85e-06	3.56e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ENO1—rheumatoid arthritis	2.83e-06	3.55e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—IL2—rheumatoid arthritis	2.83e-06	3.55e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—NFKB1—rheumatoid arthritis	2.83e-06	3.54e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL2—rheumatoid arthritis	2.82e-06	3.53e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—C3—rheumatoid arthritis	2.82e-06	3.53e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—NOS3—rheumatoid arthritis	2.81e-06	3.52e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD4—rheumatoid arthritis	2.8e-06	3.51e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.8e-06	3.51e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.78e-06	3.49e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—MED1—rheumatoid arthritis	2.78e-06	3.48e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—MAPK8—rheumatoid arthritis	2.78e-06	3.48e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	2.78e-06	3.48e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—POMC—rheumatoid arthritis	2.77e-06	3.47e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—ALB—rheumatoid arthritis	2.71e-06	3.39e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CAT—rheumatoid arthritis	2.7e-06	3.39e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	2.67e-06	3.34e-05	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	2.65e-06	3.32e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—VEGFA—rheumatoid arthritis	2.64e-06	3.31e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—LEP—rheumatoid arthritis	2.63e-06	3.29e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—IL6—rheumatoid arthritis	2.6e-06	3.26e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL1B—rheumatoid arthritis	2.59e-06	3.24e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—NOS3—rheumatoid arthritis	2.59e-06	3.24e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—CD4—rheumatoid arthritis	2.59e-06	3.24e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	2.59e-06	3.24e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	2.59e-06	3.24e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL2—rheumatoid arthritis	2.58e-06	3.23e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—PTGS2—rheumatoid arthritis	2.57e-06	3.22e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CAT—rheumatoid arthritis	2.55e-06	3.2e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—ALB—rheumatoid arthritis	2.52e-06	3.16e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—POMC—rheumatoid arthritis	2.52e-06	3.15e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—FN1—rheumatoid arthritis	2.48e-06	3.1e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL6ST—rheumatoid arthritis	2.47e-06	3.09e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TP53—rheumatoid arthritis	2.45e-06	3.07e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.44e-06	3.06e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TGFB1—rheumatoid arthritis	2.42e-06	3.04e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—NFKB1—rheumatoid arthritis	2.42e-06	3.02e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—NOS3—rheumatoid arthritis	2.41e-06	3.02e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—VEGFA—rheumatoid arthritis	2.41e-06	3.02e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—MAPK8—rheumatoid arthritis	2.37e-06	2.97e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CD80—rheumatoid arthritis	2.37e-06	2.97e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PTGS2—rheumatoid arthritis	2.37e-06	2.96e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CAT—rheumatoid arthritis	2.34e-06	2.93e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CAT—rheumatoid arthritis	2.33e-06	2.92e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—BGN—rheumatoid arthritis	2.33e-06	2.91e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—ALB—rheumatoid arthritis	2.3e-06	2.88e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	2.26e-06	2.83e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—MTHFR—rheumatoid arthritis	2.26e-06	2.83e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—POMC—rheumatoid arthritis	2.26e-06	2.82e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—IL6—rheumatoid arthritis	2.24e-06	2.81e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.23e-06	2.79e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—TGFB1—rheumatoid arthritis	2.21e-06	2.77e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTGS2—rheumatoid arthritis	2.21e-06	2.76e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCL2—rheumatoid arthritis	2.21e-06	2.76e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL6R—rheumatoid arthritis	2.2e-06	2.76e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—NOS3—rheumatoid arthritis	2.2e-06	2.75e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	2.14e-06	2.68e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—MTHFR—rheumatoid arthritis	2.13e-06	2.67e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CAT—rheumatoid arthritis	2.04e-06	2.55e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTGS2—rheumatoid arthritis	2.01e-06	2.52e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TYK2—rheumatoid arthritis	2e-06	2.51e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TP53—rheumatoid arthritis	2e-06	2.5e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NOS3—rheumatoid arthritis	1.97e-06	2.46e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—MTHFR—rheumatoid arthritis	1.95e-06	2.45e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.95e-06	2.44e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—MTHFR—rheumatoid arthritis	1.94e-06	2.43e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CAT—rheumatoid arthritis	1.92e-06	2.41e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—TGFB1—rheumatoid arthritis	1.86e-06	2.33e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—IL6—rheumatoid arthritis	1.83e-06	2.29e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—TP53—rheumatoid arthritis	1.82e-06	2.28e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—POMC—rheumatoid arthritis	1.8e-06	2.26e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—IL6—rheumatoid arthritis	1.77e-06	2.22e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	1.75e-06	2.19e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CXCL8—rheumatoid arthritis	1.75e-06	2.18e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—POMC—rheumatoid arthritis	1.71e-06	2.13e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	1.7e-06	2.13e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL2—rheumatoid arthritis	1.67e-06	2.09e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—IL6—rheumatoid arthritis	1.66e-06	2.08e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ALB—rheumatoid arthritis	1.65e-06	2.06e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CAT—rheumatoid arthritis	1.63e-06	2.04e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	1.6e-06	2.01e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MMP9—rheumatoid arthritis	1.58e-06	1.98e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—NOS3—rheumatoid arthritis	1.57e-06	1.97e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—POMC—rheumatoid arthritis	1.56e-06	1.96e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NFKB1—rheumatoid arthritis	1.56e-06	1.96e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ALB—rheumatoid arthritis	1.55e-06	1.95e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—POMC—rheumatoid arthritis	1.55e-06	1.95e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MAPK8—rheumatoid arthritis	1.54e-06	1.92e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—IL6—rheumatoid arthritis	1.52e-06	1.9e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—NOS3—rheumatoid arthritis	1.49e-06	1.86e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTGS2—rheumatoid arthritis	1.44e-06	1.8e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ALB—rheumatoid arthritis	1.43e-06	1.78e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—VEGFA—rheumatoid arthritis	1.42e-06	1.77e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—IL6—rheumatoid arthritis	1.4e-06	1.75e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—NOS3—rheumatoid arthritis	1.36e-06	1.71e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—POMC—rheumatoid arthritis	1.36e-06	1.7e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTGS2—rheumatoid arthritis	1.36e-06	1.7e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	1.36e-06	1.7e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—NOS3—rheumatoid arthritis	1.36e-06	1.7e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TGFB1—rheumatoid arthritis	1.3e-06	1.63e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—POMC—rheumatoid arthritis	1.28e-06	1.61e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CAT—rheumatoid arthritis	1.26e-06	1.57e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTGS2—rheumatoid arthritis	1.25e-06	1.56e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ALB—rheumatoid arthritis	1.24e-06	1.55e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTGS2—rheumatoid arthritis	1.24e-06	1.55e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—NOS3—rheumatoid arthritis	1.19e-06	1.49e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ALB—rheumatoid arthritis	1.17e-06	1.46e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	1.12e-06	1.4e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—POMC—rheumatoid arthritis	1.09e-06	1.36e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	1.09e-06	1.36e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TP53—rheumatoid arthritis	1.07e-06	1.34e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	1.05e-06	1.31e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	1.02e-06	1.28e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ALB—rheumatoid arthritis	9.91e-07	1.24e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—IL6—rheumatoid arthritis	9.8e-07	1.23e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	9.48e-07	1.19e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	8.67e-07	1.09e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—POMC—rheumatoid arthritis	8.39e-07	1.05e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ALB—rheumatoid arthritis	7.65e-07	9.58e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	7.32e-07	9.16e-06	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	6.69e-07	8.38e-06	CbGpPWpGaD
